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Abstract— This study investigated the possible interplay ef-
fects arising from the treatment of moving targets using the 
dynamic conformal arc therapy (DCAT) technique. Dose from 
a modulated test beam was measured, with and without phan-
tom motion and with and without a 30o arc rotation, using a 
diode array placed on a sinusoidally moving platform.  Meas-
urements were repeated at five different collimator angles (0, 
22.5, 45, 67.5 and 90o), at two different dose rates (300 and 600 
MU/min). Results showed that the effect of respiratory motion 
on the measured dose distribution increased slightly when the 
beams were delivered as arcs, rather than with a static gantry 
angle, and that this effect increased substantially as the colli-
mator angle was increased from 0o (MLC motion perpendicu-
lar to respiratory motion) to 90o (MLC motion parallel to 
respiratory motion). The dose oscillations arising from inter-
play between phantom and MLC motion were found to in-
crease in magnitude when the dose rate was increased. These 
results led to the development of simple recommendations for 
minimizing the negative effects of motion interplay on DCAT 
dose distributions. 
Keywords— Radiation therapy, arc therapy, rotational 
IMRT, respiratory motion. 
I. INTRODUCTION  
This study investigated the possible interplay effects aris-
ing from the treatment of moving targets using the DCAT 
(dynamic conformal arc therapy) radiotherapy technique.  
Interplay effects, including dose blurring (also called 
“dose smoothing” or the “dose gradient effect”) and local-
ized dose variations [1,2,3] (seen as dose stepping when 
dynamically wedged fields are delivered to moving phan-
toms [3,4]) have been shown to arise from the treatment of 
moving anatomy with dynamic radiation beams, including 
intensity modulated radiotherapy (IMRT) beams [5,6,7]. 
Dynamically wedged beams and IMRT beams involve the 
use of collimators that sweep from one side of the radiation 
field to the other, while the targeted anatomy moves either 
in the same direction as the collimators (leading to locally 
increased dose), the opposite direction from the collimators 
(leading to locally decreased dose), or in a direction uncor-
related with the collimators (leading to dose blurring).  
While several planning simulation studies have shown 
that interplay between MLC motion and respiratory motion 
can have a negligible impact on volumetric-modulated arc 
therapy (VMAT) dose delivery, even with the additional 
motion provided by the rotating gantry [8,9], the potential 
for inaccurate VMAT treatment delivery remains a concern, 
especially when single-fraction, stereotactic ablative radio-
therapy (SABR) treatments are contemplated [10,11]. 
While VMAT treatments involve complex arrangements 
of MLC leaves, rapidly moving back and forth across the 
radiation field, DCAT treatments are geometrically simpler, 
and more similar to static 3D conformal radiotherapy 
(3DCRT) treatments, with MLC leaves simply matching the 
external contour of the target throughout gantry rotation 
[12]. This geometric similarity between DCAT treatment 
plans and 3DCRT treatment plans leads to the frequent 
assumption that DCAT treatments are, like 3DCRT treat-
ments, not affected by the MLC interplay effect [10,12]. 
 
Fig. 1 Plot of MLC leaf displacements vs gantry angles for (a) a VMAT 
treatment delivered to an off-axis target and (b) a DCAT treatment deliv-
ered to an off-axis target. 
However, when the DCAT technique is used to treat lat-
eral targets, such as peripheral lung tumors, it is often nec-
essary to shift the treatment isocentre medially, away from 
the center of the tumor volume, in order to avoid possible 
collisions between the linac head and the treatment couch. 
In such situations, the MLC apertures that define the DCAT 
beam do not remain centered around the collimator axis but 
rather move from one side of the field to the other and back 
again, during the gantry rotation (see Figure 1). In this situa-
tion, the dynamic MLC leaf arrangement produced by the 
DCAT plan is more reminiscent of an IMRT treatment, than 
either a VMAT treatment or a 3DCRT treatment. 
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Given the known susceptibility of IMRT treatment 
beams to the effects of motion interplay [5,6,7], it is there-
fore important to determine whether this susceptibility also 
affects DCAT treatment beams, in order to evaluate the 
suitability of the DCAT technique for use in SABR treat-
ments of peripheral lung tumors. 
II. MATERIALS AND METHODS 
In order to investigate the possible effects of MLC, gan-
try and phantom motion interplay, dose from a series of 
simple dynamic arcs was measured using a MapCheck 2 
diode array (Sun Nuclear Corp., Melbourne, USA) placed 
on a QUASAR respiratory motion platform (Modus Medi-
cal Devices Inc, London, Canada). Water-equivalent plastic 
with a total thickness of 1.5 cm was placed on top of the 
diode array, to provide electron build-up, at 105 cm source-
to-surface distance. 
Nominal 6 MV photon beams were delivered to the diode 
array by a Varian iX linear accelerator (Varian Medical 
Systems, Palo Alto, USA), collimated using a sliding win-
dow "chair test" MLC pattern [13]. The chair test was se-
lected for use in this work because: is both familiar and 
complex, being one of the standard tests used for MLC 
evaluation; it contains sections where MLC apertures are 
narrowly and widely spaced, making it useful for evaluating 
the effects of MLC aperture sizes on results; it requires 
groups of MLC leaves to move at constant but differing 
speeds, making it useful for evaluating leaf speed effects; it 
uses leaves that all move in the same direction, so it pro-
vides a useful approximation to a DCAT delivery to an off-
axis target; and the resulting dose distribution contains regu-
lar, orthogonal high-dose sections, that allow the easy iden-
tification of dose distortion. 
Reference measurements were made with the motion 
platform switched off and with the beam oriented at a 0° 
gantry angle. Dynamic measurements were made over a 30° 
arc, between gantry angles of 345 to 15°, to minimize the 
effects of the diode array's angular response [14]. Reference 
and arc measurements were repeated at five different colli-
mator angles (0, 22.5, 45, 67.5 and 90°), at two different 
dose rates (300 and 600 MU/min), allowing the relative 
effects of leaf motion and leaf speed to be evaluated. When 
in use, the motion platform provided regular, longitudinal 
(superior-inferior), sinusoidal motion, with a 40 mm peak-
to-peak amplitude and a 4 s period. 
Measurements at the different collimator angles, with and 
without gantry rotation, with and without phantom motion 
were compared, in terms of the percentage of measurement 
points that agreed within a 5% threshold, using MapCheck 
measurement analysis software.  The MapCheck software 
was also used to acquire dose profile data. 
III. RESULTS AND DISCUSSION 
Figure 2 shows a selection of screenshots from the Map-
Check software interface, exemplifying the effects of arc 
motion and respiratory motion on the dose delivered by the 
MLC chair test pattern. The top two rows indicate the effect 
of respiratory motion on an IMRT delivery, without arc 
rotation, and suggest that some dose blurring in the direc-
tion of phantom motion is combined with a dose oscillation 
effect in the direction of MLC motion, which becomes in-
creasingly obvious as the MLC motion direction moves 
closer to the phantom motion direction. This dose oscilla-
tion results from regions of increased dose (where the phan-
tom and MLCs are both moving in the same direction) al-
ternating with regions of decreased dose (where the 
phantom and the MLCs are moving in opposite directions) 
and is analogous to the dose stepping effect seen in dynamic 
wedge deliveries to moving phantoms [3]. 
 
Fig. 2 MapCheck screenshots showing measurement results obtained 
without gantry rotation and without phantom motion (first row), without 
gantry rotation and with phantom motion (second row), with gantry rota-
tion and without phantom motion (third row) and with gantry rotation and 
with phantom motion (fourth row). Collimator angles increase from 0° to 
90°, from left to right. In all panels, the phantom motion is up and down the 
page and the MLC motion direction is from the back of the chair to the 
front of the chair. In the lower two rows, the direction of arc rotation is 
from the left to the right. 
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The lower two rows in Figure 2 show the effect of respir-
atory motion on a dynamic conformal arc delivery, and 
suggest that the combined effects of respiratory motion and 
arc motion led to increased lateral dose blurring, without 
reducing the appearance of dose oscillations across the 
phantom. These effects are quantified in Figures 3(a)-(f). 
 
Fig. 3 Dose profiles derived from MapCheck 2 measurements acquired 
with (a) without gantry rotation and without phantom motion, (b) with 
gantry rotation and without phantom motion, (c) without gantry rotation 
and with phantom motion (300 MU/min), (d) with gantry rotation and with 
phantom motion (300 MU/min), (e) without gantry rotation and with 
phantom motion (600 MU/min) and (f) with gantry rotation and with 
phantom motion (600 MU/min). 
Figures 3(a)-(f) show dose profiles (angled to match the 
collimator angles used to deliver each beam) through the 
center of the seat in the chair pattern, derived from the 
MapCheck 2 measurement data. As suggested by the imag-
es in Figure 2, these dose profiles show dose oscillations 
throughout the high-dose region when the phantom is in 
motion (Figures 3(c)-(f)), increased blurring (broader pe-
numbrae) when motion is combined with arc delivery com-
pared to motion alone, without any corresponding reduction 
in the magnitude of the dose oscillations.  
Comparison of Figures 3(c) and (d) with Figures 3(e) and 
(f) indicates that the dose oscillations arising from interplay 
between phantom and MLC motion are enhanced when the 
dose rate at which the beam is delivered is increased from 
300 MU/min to 600 MU/min, effectively halving the time 
taken to deliver each beam. Given Ong et al’s recent obser-
vation that interplay effects that are not apparent in VMAT 
treatments delivered at 400 MU/min become significant 
when the dose rate is increased to 2400 MU/min [15], it is 
possible to conclude that speeding up the treatment delivery 
reduces the opportunity for interplay effects to blur out over 
sequential respiratory cycles.  
Figure 4 provides a broad comparison of these results, 
showing the percentage of points measured with the phan-
tom in motion that achieving agreement within 5% when 
compared with commensurate points measured with the 
phantom stationary. Data in Figure 4 show that the effect of 
respiratory motion on dose delivery increases slightly when 
the beams are delivered as arcs, rather than with a static 
gantry angle, and increases substantially as the collimator 
angle increases from 0° (MLC motion perpendicular to 
respiratory motion) to 90° (MLC motion parallel to respira-
tory motion). These results also show poorer agreement 
between the stationary and moving phantom results, in 
almost all cases, when the higher dose rate (shorter treat-
ment time) is used.  
 
Fig. 4 Summary of measurements: percentage of points agreeing (within 
5%) when the phantom is stationary and moving, for each collimator angle. 
IV. CONCLUSIONS  
The results of this study suggest that treatment beams de-
livered as dynamic conformal arcs may be affected by the 
interplay of MLC motion and patient respiratory motion, to 
a similar degree as static gantry IMRT treatment beams, 
rather than being similar to VMAT beams and largely im-
mune to the effects of motion interplay. 
For DCAT beams, like IMRT beams, the negative effects 
of motion interplay may be minimized by aligning the col-
limator as close to perpendicular to the dominant direction 
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of respiratory motion as possible (if interleaf leakage from 
the MLC is also minimized by avoiding an exact 0° collima-
tor angle), by decreasing the dose rate and thereby increas-
ing the total delivery time of each beam, and by including 
appropriate margins on treatment targets so that dose blur-
ring at the edges of the beam does not compromise tumor 
control.  
The combination of a complex and narrow beam geome-
try with a relatively large respiratory motion amplitude 
means that the measurements described in this study pro-
vide a useful worst-case-scenario and an informative start-
ing point for further studies. 
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